MS
AZN icon

Maven Securities’s AstraZeneca AZN Stock Holding History

Maven Securities’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,800
Closed -$380K – 918
2022
Q4 		$380K Sell
2,800
-2,250
-45% -$282K 0.01% 635
2022
Q3 		$554K Buy
5,050
+3,400
+206% +$431K 0.01% 758
2022
Q2 		$218K Buy
+1,650
New +$216K 0.01% 828

Other funds holding AZN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Maven Securities's AZN Position: Q1 2023 in Review

Maven Securities sold out of AstraZeneca (AZN) in Q1 2023, closing a stake of 2,506 shares — an estimated $337K sold.

Maven Securities first reported a position in AZN in Q1 2019 and held it in 5 quarters. The position peaked at $3.88M in Q1 2019. 1,055 funds tracked by Wall St. Rank hold AZN as of Q1 2023.

  • Maven Securities reported no remaining AstraZeneca position as of Q1 2023 after selling out during the quarter.
  • Maven Securities sold 2,506 AstraZeneca shares in Q1 2023, an estimated $337K.
  • Maven Securities first reported a position in AstraZeneca in Q1 2019 and held it in 5 quarters.
  • Maven Securities's AstraZeneca position peaked at $3.88M in Q1 2019.
  • 1,055 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2023.

Based on Maven Securities's 13F filing for Q1 2023, filed 15 May 2023.